These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Monofunctional platinum-DNA adducts are strong inhibitors of transcription and substrates for nucleotide excision repair in live mammalian cells. Zhu G; Myint M; Ang WH; Song L; Lippard SJ Cancer Res; 2012 Feb; 72(3):790-800. PubMed ID: 22180496 [TBL] [Abstract][Full Text] [Related]
3. Transcription inhibition by platinum-DNA cross-links in live mammalian cells. Ang WH; Myint M; Lippard SJ J Am Chem Soc; 2010 Jun; 132(21):7429-35. PubMed ID: 20443565 [TBL] [Abstract][Full Text] [Related]
4. Poly(ADP-ribose) polymerase-1 activity facilitates the dissociation of nuclear proteins from platinum-modified DNA. Guggenheim ER; Ondrus AE; Movassaghi M; Lippard SJ Bioorg Med Chem; 2008 Dec; 16(23):10121-8. PubMed ID: 18977144 [TBL] [Abstract][Full Text] [Related]
5. Platinated benzonaphthyridone is a stronger inhibitor of poly(ADP-ribose) polymerase-1 and a more potent anticancer agent than is the parent inhibitor. Wang B; Qian H; Yiu SM; Sun J; Zhu G Eur J Med Chem; 2014 Jan; 71():366-73. PubMed ID: 24361480 [TBL] [Abstract][Full Text] [Related]
6. Multiple states of stalled T7 RNA polymerase at DNA lesions generated by platinum anticancer agents. Jung Y; Lippard SJ J Biol Chem; 2003 Dec; 278(52):52084-92. PubMed ID: 14534300 [TBL] [Abstract][Full Text] [Related]
7. Protein interactions with platinum-DNA adducts: from structure to function. Chaney SG; Campbell SL; Temple B; Bassett E; Wu Y; Faldu M J Inorg Biochem; 2004 Oct; 98(10):1551-9. PubMed ID: 15458816 [TBL] [Abstract][Full Text] [Related]
8. PARP1 impact on DNA repair of platinum adducts: preclinical and clinical read-outs. Olaussen KA; Adam J; Vanhecke E; Vielh P; Pirker R; Friboulet L; Popper H; Robin A; Commo F; Thomale J; Kayitalire L; Filipits M; Le Chevalier T; André F; Brambilla E; Soria JC Lung Cancer; 2013 May; 80(2):216-22. PubMed ID: 23410825 [TBL] [Abstract][Full Text] [Related]
9. Spontaneous translocation of antitumor oxaliplatin, its enantiomeric analogue, and Cisplatin from one strand to another in double-helical DNA. Malina J; Natile G; Brabec V Chemistry; 2013 Sep; 19(36):11984-91. PubMed ID: 23873652 [TBL] [Abstract][Full Text] [Related]
10. Photoaffinity isolation and identification of proteins in cancer cell extracts that bind to platinum-modified DNA. Guggenheim ER; Xu D; Zhang CX; Chang PV; Lippard SJ Chembiochem; 2009 Jan; 10(1):141-57. PubMed ID: 19053130 [TBL] [Abstract][Full Text] [Related]
11. Solution structures of a DNA dodecamer duplex with and without a cisplatin 1,2-d(GG) intrastrand cross-link: comparison with the same DNA duplex containing an oxaliplatin 1,2-d(GG) intrastrand cross-link. Wu Y; Bhattacharyya D; King CL; Baskerville-Abraham I; Huh SH; Boysen G; Swenberg JA; Temple B; Campbell SL; Chaney SG Biochemistry; 2007 Jun; 46(22):6477-87. PubMed ID: 17497831 [TBL] [Abstract][Full Text] [Related]
12. Energetics, conformation, and recognition of DNA duplexes containing a major adduct of an anticancer azolato-bridged dinuclear Pt(II) complex. Mlcouskova J; Malina J; Novohradsky V; Kasparkova J; Komeda S; Brabec V Biochim Biophys Acta; 2012 Oct; 1820(10):1502-11. PubMed ID: 22683702 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, Cytotoxicity, and Mechanistic Investigation of Platinum(IV) Anticancer Complexes Conjugated with Poly(ADP-ribose) Polymerase Inhibitors. Xu Z; Li C; Zhou Q; Deng Z; Tong Z; Tse MK; Zhu G Inorg Chem; 2019 Dec; 58(23):16279-16291. PubMed ID: 31738050 [TBL] [Abstract][Full Text] [Related]
15. Recognition of DNA interstrand cross-links of cis-diamminedichloroplatinum(II) and its trans isomer by DNA-binding proteins. Kaspárková J; Brabec V Biochemistry; 1995 Sep; 34(38):12379-87. PubMed ID: 7547982 [TBL] [Abstract][Full Text] [Related]
16. 2.4 A crystal structure of an oxaliplatin 1,2-d(GpG) intrastrand cross-link in a DNA dodecamer duplex. Spingler B; Whittington DA; Lippard SJ Inorg Chem; 2001 Oct; 40(22):5596-602. PubMed ID: 11599959 [TBL] [Abstract][Full Text] [Related]
17. Unique properties of DNA interstrand cross-links of antitumor oxaliplatin and the effect of chirality of the carrier ligand. Kasparkova J; Vojtiskova M; Natile G; Brabec V Chemistry; 2008; 14(4):1330-41. PubMed ID: 18022972 [TBL] [Abstract][Full Text] [Related]
18. Poly(ADP-ribose) polymerase-1 protects excessive DNA strand breaks from deterioration during repair in human cell extracts. Parsons JL; Dianova II; Allinson SL; Dianov GL FEBS J; 2005 Apr; 272(8):2012-21. PubMed ID: 15819892 [TBL] [Abstract][Full Text] [Related]
19. East-west fusion-necrosis and apoptosis acting in concert by demethylcantharidin-integrated platinum complexes. Pang SK; So WK; Ho YP; Au-Yeung CF Anticancer Agents Med Chem; 2014 Jun; 14(5):756-61. PubMed ID: 24476313 [TBL] [Abstract][Full Text] [Related]
20. Characterization of a DNA damage-recognition protein from mammalian cells that binds specifically to intrastrand d(GpG) and d(ApG) DNA adducts of the anticancer drug cisplatin. Donahue BA; Augot M; Bellon SF; Treiber DK; Toney JH; Lippard SJ; Essigmann JM Biochemistry; 1990 Jun; 29(24):5872-80. PubMed ID: 2383564 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]